Home Pharmaceuticals Southeast Asia IVD Raw Materials Market Size And Share Report By 2033

Southeast Asia IVD Raw Materials Market Size & Outlook, 2025-2033

Southeast Asia IVD Raw Materials Market Size

According to Straits Research analysis, the Southeast Asia IVD Raw Materials Market was valued at USD 431.93 Million in 2024 and is projected to reach USD 1392.89 Million by 2033, expanding at a CAGR of 14% during the forecast period. This growth is primarily fueled by surging demand in industries such as healthcare, agriculture, and energy, where these materials are needed for diagnostics, crop improvement, and renewable energy technologies respectively. Emerging trends in green production and sustainability coupled with technological advancements further provide significant opportunities for market expansion. Export potential, especially in the backdrop of global supply chain shifts, also serves as a key growth driver for the market. Southeast Asia, with its strategic location and increasing technological competence, is positioning itself as an important hub in the global IVD raw materials market.

Southeast Asia IVD Raw Materials Market Highlights

  • Within the Product Type category, Antibody dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Proteins is forecasted to deliver the fastest growth, positioning it as the most lucrative Product Type segment.
  • In 2024, Southeast Asia accounted for 2.65% of the global ivd raw materials market size.
  • By 2033, United States is expected to lead the global ivd raw materials market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional ivd raw materials market size by 2033.
  • India is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 454.85 Million by 2033.

Southeast Asia IVD Raw Materials Market Revenue Share 2024

  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2020-2033
Historical Period 2020-2023
Forecast Period 2025-2033
Market Size In 2024 USD 431.93 Million
Market Size In 2033 USD 1392.89 Million
Largest segment Antibody
Fastest segment Proteins
Units Revenue in USD Million
CAGR 14% (2025-2033)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Segmentation Covered

Segments Sub Segments
Product Type
  1. Antibody
  2. Antigens
  3. Proteins
  4. Enzymes
  5. Biological Buffers
  6. Substrates
  7. Others
Technology
  1. Molecular Diagnostics
  2. Clinical Chemistry
  3. Immunochemistry
  4. Other
End User
  1. Diagnostic Laboratories
  2. Pharmaceutical & Biotechnological Companies
  3. Others
WhatsApp
Chat with us on WhatsApp